Stay updated on RC48-ADC in HER2+ Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section now lists new sites (Anhui, Beijing Municipality, Guangdong, Hunan, Shandong, Sichuan) and removes the old location blocks, reflecting updated site availability.SummaryDifference0.8%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe updates consist of a wording change to the Publications note and a revision version marker. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe NIH funding/operating status notice at the bottom of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedThe new screenshot shows only formatting and layout adjustments with no changes to the study's design, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check98 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.1%

Stay in the know with updates to RC48-ADC in HER2+ Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.